BackIndo US Bio-Tech Limited Overview
Indo US Bio-Tech Limited

Indo US Bio-Tech Limited Return on Equity

Indo US Bio-Tech Limited (INDOUS.BO) has a ROE of 4.72%, below the sector sector average of 10.27%.

Get informed when a big investor buys or sells

+ Follow

ROE

4.72%

Return on Equity

4.72%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Indo US Bio-Tech Limited (INDOUS.BO) FAQ

The latest ROE for INDOUS.BO is 4.72%. That is below the sector sector average of 10.27%. Investors often review this figure alongside Indo US Bio-Tech Limited's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, INDOUS.BO currently prints 4.72% for ROE, while the sector average sits near 10.27%. That is roughly 54.1% below the sector mean. Large gaps often invite a closer look at Indo US Bio-Tech Limited's growth, margins, and balance sheet.

Return on Equity shows how effectively Indo US Bio-Tech Limited converts resources into returns. At 4.72%, INDOUS.BO may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting INDOUS.BO's ROE (4.72%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers